Autor: |
Shan, Li, Peng-Sheng, Zheng, Hong Mei, Ma, Qian, Feng, Yan Ru, Zhang, Qin Shu, Li, Jing Jing, He, Wen Fang, Liu |
Rok vydání: |
2022 |
Předmět: |
|
Zdroj: |
Fertility and Sterility. 118:906-914 |
ISSN: |
0015-0282 |
DOI: |
10.1016/j.fertnstert.2022.08.008 |
Popis: |
To evaluate the current evidence of pregnancy outcomes among couples with recurrent pregnancy loss (RPL) with abnormal karyotypes vs. those with normal karyotypes and among couples with RPL and abnormal karyotypes after receiving expectant management vs. preimplantation genetic diagnosis (PGD).Systematic review and meta-analysis.Academic medical centers.Pregnancy outcomes in 6,301 couples with RPL who conceived without medical intervention in 11 studies were analyzed. However, only 2 studies addressed the outcomes of couples with RPL and abnormal karyotypes after expectant management (75 cases) vs. PGD (50 cases).None.The pregnancy outcomes in couples with RPL with abnormal and normal karyotypes across included studies were evaluated.Compared with those with a normal karyotype, a significantly lower first pregnancy live birth rate (LBR) was found in couples with RPL with abnormal karyotypes (58.5% vs. 71.9%; odds ratio [OR], 0.55; 95% confidence interval [CI], 0.46-0.65; ICouples with RPL and abnormal karyotypes had a higher miscarriage rate than couples with normal karyotypes but achieved a noninferior accumulated LBR through multiple conception attempts. In couples with RPL and abnormal karyotypes, PGD treatment did not increase the accumulated LBR but markedly reduced miscarriage rate compared with expectant management. |
Databáze: |
OpenAIRE |
Externí odkaz: |
|